Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes
  2. Franquelim, H. G.; Chiantia, S.; Veiga, A. S.; Santos, N. C.; Schwille, P.; Castanho, M.
  3. Aids. 2011, Feb; 25(4): 419-428.
  1. 2.   Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens
  2. Zhang, M. Y.; Vu, B. K.; Choudhary, A.; Lu, H.; Humbert, M.; Ong, H.; Alam, M.; Ruprecht, R. M.; Quinnan, G.; Jiang, S.; Montefiori, D. C.; Mascola, J. R.; Broder, C. C.; Haynes, B. F.; Dimitrov, D. S.
  3. Journal of Virology. 2008 82(14): 6869-6879.
  1. 3.   Electron tomography of the contact between T cells and SIV/HIV-1: Implications for viral entry
  2. Sougrat, R.; Bartesaghi, A.; Lifson, J. D.; Bennett, A. E.; Bess, J. W.; Zabransky, D. J.; Subramaniam, S.
  3. Plos Pathogens. 2007, May; 3(5): 571-581.
  1. 4.   Distribution and three-dimensional structure of AIDS virus envelope spikes
  2. Zhu, P.; Liu, J.; Bess, J.; Chertova, E.; Lifson, J. D.; Grise, H.; Ofek, G. A.; Taylor, K. A.; Roux, K. H.
  3. Nature. 2006, JUN 15; 441(7095): 847-852.
  1. 5.   Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation
  2. Vaillant, A.; Juteau, J. M.; Lu, H.; Liu, S. W.; Lackman-Smith, C.; Ptak, R.; Jiang, S. B.
  3. Antimicrobial Agents and Chemotherapy. 2006, Apr; 50(4): 1393-1401.
  1. 6.   Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain
  2. Jaroniec, C. P.; Kaufman, J. D.; Stahl, S. J.; Viard, M.; Blumenthal, R.; Wingfield, P. T.; Bax, A.
  3. Biochemistry. 2005, DEC 13; 44(49): 16167-16180.
  1. 7.   Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail
  2. Wyss, S.; Dimitrov, A. S.; Baribaud, F.; Edwards, T. G.; Blumenthal, R.; Hoxie, J. A.
  3. Journal of Virology. 2005, OCT; 79(19): 12231-12241.
  1. 8.   Isolation and characterization of anti-HIV peptides from Dorstenia contrajerva and Treculia obovoidea
  2. Bokesch, H. R.; Charan, R. D.; Meragelman, K. M.; Beutler, J. A.; Gardella, R.; O'Keefe, B. R.; McKee, T. C.; McMahon, J. B.
  3. Febs Letters. 2004 567(2-3): 287-290.
  1. 10.   Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: Evidence for virion- associated lipid rafts
  2. Graham, D. R. M.; Chertova, E.; Hilburn, J. M.; Arthur, L. O.; Hildreth, J. E. K.
  3. Journal of Virology. 2003 77(15): 8237-8248.
  1. 11.   Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates
  2. Golding, H.; Zaitseva, M.; de Rosny, E.; King, L. R.; Manischewitz, J.; Sidorov, I.; Gorny, M. K.; Zolla-Pazner, S.; Dimitrov, D. S.; Weiss, C. D.
  3. Journal of Virology. 2002 76(13): 6780-6790.
  1. 12.   Membrane-induced conformational change during the activation of HIV-1 gp41
  2. Kliger, Y.; Peisajovich, S. G.; Blumenthal, R.; Shai, Y.
  3. Journal of Molecular Biology. 2000 301(4): 905-914.
  1. 13.   Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion
  2. Munoz-Barroso, I.; Salzwedel, K.; Hunter, E.; Blumenthal, R.
  3. Journal of Virology. 1999 73(7): 6089-6092.
  1. 14.   Three-Dimensional Solution Structure of the 44 Kda Ectodomain of Siv Gp41
  2. Caffrey, M.; Cai, M. L.; Kaufman, J.; Stahl, S. J.; Wingfield, P. T.; Covell, D. G.; Gronenborn, A. M.; Clore, G. M.
  3. Embo Journal. 1998 17(16): 4572-4584.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel